ASTH
Price
$29.70
Change
-$1.12 (-3.63%)
Updated
Sep 5 closing price
Capitalization
1.37B
54 days until earnings call
SRXH
Price
$0.38
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
12.45M
Interact to see
Advertisement

ASTH vs SRXH

Header iconASTH vs SRXH Comparison
Open Charts ASTH vs SRXHBanner chart's image
Astrana Health
Price$29.70
Change-$1.12 (-3.63%)
Volume$359.39K
Capitalization1.37B
SRX Health Solutions
Price$0.38
Change-$0.00 (-0.00%)
Volume$808.46K
Capitalization12.45M
ASTH vs SRXH Comparison Chart in %
Loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASTH vs. SRXH commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and SRXH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ASTH: $29.70 vs. SRXH: $0.38)
Brand notoriety: ASTH and SRXH are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 94% vs. SRXH: 5%
Market capitalization -- ASTH: $1.37B vs. SRXH: $12.45M
ASTH [@Hospital/Nursing Management] is valued at $1.37B. SRXH’s [@Hospital/Nursing Management] market capitalization is $12.45M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $98.46B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileSRXH’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • SRXH’s FA Score: 1 green, 4 red.
According to our system of comparison, ASTH is a better buy in the long-term than SRXH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish while SRXH’s TA Score has 4 bullish TA indicator(s).

  • ASTH’s TA Score: 4 bullish, 6 bearish.
  • SRXH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SRXH is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -7.07% price change this week, while SRXH (@Hospital/Nursing Management) price change was -10.24% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.46%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +7.87%.

Reported Earning Dates

ASTH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Hospital/Nursing Management (+0.46% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASTH($1.37B) has a higher market cap than SRXH($12.4M). ASTH YTD gains are higher at: -5.804 vs. SRXH (-84.043). ASTH has more cash in the bank: 342M vs. SRXH (1.14M). SRXH has less debt than ASTH: SRXH (1.28M) vs ASTH (448M).
ASTHSRXHASTH / SRXH
Capitalization1.37B12.4M11,056%
EBITDA112MN/A-
Gain YTD-5.804-84.0437%
P/E Ratio57.12N/A-
Revenue2.42BN/A-
Total Cash342M1.14M30,079%
Total Debt448M1.28M35,000%
FUNDAMENTALS RATINGS
ASTH vs SRXH: Fundamental Ratings
ASTH
SRXH
OUTLOOK RATING
1..100
2095
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
88100
PRICE GROWTH RATING
1..100
4395
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
1232

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRXH's Valuation (20) in the null industry is somewhat better than the same rating for ASTH (76). This means that SRXH’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's Profit vs Risk Rating (87) in the null industry is in the same range as SRXH (100). This means that ASTH’s stock grew similarly to SRXH’s over the last 12 months.

ASTH's SMR Rating (88) in the null industry is in the same range as SRXH (100). This means that ASTH’s stock grew similarly to SRXH’s over the last 12 months.

ASTH's Price Growth Rating (43) in the null industry is somewhat better than the same rating for SRXH (95). This means that ASTH’s stock grew somewhat faster than SRXH’s over the last 12 months.

ASTH's P/E Growth Rating (12) in the null industry is significantly better than the same rating for SRXH (100). This means that ASTH’s stock grew significantly faster than SRXH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHSRXH
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWEGX39.65N/A
N/A
MFS Global Equity R1
MOJAX15.73N/A
N/A
Donoghue Forlines Momentum A
CRTVX12.36N/A
N/A
Catholic Rsp Invst Mlt-Styl US Eq Inv
BIRDX8.48N/A
N/A
iShares Developed Real Estate Idx Instl
RTLCX84.01-0.18
-0.21%
Russell Inv Tax-Managed US Large Cap C

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-3.63%
ACHC - ASTH
45%
Loosely correlated
+0.30%
DCGO - ASTH
40%
Loosely correlated
+4.64%
LFST - ASTH
35%
Loosely correlated
-1.83%
AMN - ASTH
35%
Loosely correlated
+3.06%
AIRS - ASTH
35%
Loosely correlated
-0.34%
More

SRXH and

Correlation & Price change

A.I.dvisor tells us that SRXH and SEM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRXH and SEM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRXH
1D Price
Change %
SRXH100%
-1.83%
SEM - SRXH
26%
Poorly correlated
+0.69%
LFST - SRXH
21%
Poorly correlated
-1.83%
EHC - SRXH
7%
Poorly correlated
+0.88%
TOI - SRXH
7%
Poorly correlated
+1.23%
NIVF - SRXH
4%
Poorly correlated
+3.39%
More